PASADENA, Calif. (AP) _ Arrowhead Research Corp. (ARWR) on Friday reported a loss of $13.2 million in its fiscal first quarter.
The Pasadena, California-based company said it had a loss of 18 cents per share.
The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 18 cents per share.
The drug developer posted revenue of $3.5 million in the period.
Arrowhead Research shares have increased 53 percent since the beginning of the year. In the final minutes of trading on Friday, shares hit $5.64, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARWR at https://www.zacks.com/ap/ARWR